Healthcare professionals

Image for Healthcare professionals
Image for Healthcare professionals

OUR PAH FRANCHISE

Image for Opsumit®

Opsumit(macitentan), an orally available endothelin receptor antagonist, resulted from a tailored drug discovery process in Actelion’s laboratories.



US residents only: www.opsumit.com

 
Image for Opsumit®

Opsumit(macitentan), an orally available endothelin receptor antagonist, resulted from a tailored drug discovery process in Actelion’s laboratories.



US residents only: www.opsumit.com

 
 

OUR SPECIALTY PRODUCTS

Image for Valchlor®

Zavesca (miglustat) available as oral capsules, is a glucosylceramide synthase inhibitor indicated as monotherapy for the treatment of adult patients with mild to moderate type I Gaucher disease for whom enzyme replacement therapy is not a therapeutic option. Zavesca is approved in 47 countries.Zavesca is approved for the treatment of Niemann-Pick type C disease in 45 countries.

US residents only: www.valchlor.com

 
Image for Valchlor®

Zavesca (miglustat) available as oral capsules, is a glucosylceramide synthase inhibitor indicated as monotherapy for the treatment of adult patients with mild to moderate type I Gaucher disease for whom enzyme replacement therapy is not a therapeutic option. Zavesca is approved in 47 countries.Zavesca is approved for the treatment of Niemann-Pick type C disease in 45 countries.

US residents only: www.valchlor.com

 
 

US RESIDENTS

Please note that the information contained in this section of the website is not intended for US residents. Please visit our US webpage.

Please note that the information contained in this section of the website is not intended for US residents. Please visit our US webpage.

DISEASES

Image for DU

Digital ulcers are very painful and result in difficult-to-heal open sores that occur on fingers and toes.

 
Image for DU

Digital ulcers are very painful and result in difficult-to-heal open sores that occur on fingers and toes.

 
 

PAH

Image for PAH

Pulmonary arterial hypertension (PAH) is a serious disease of the arteries connecting the lungs to the heart (the pulmonary arteries).

Image for PAH

Pulmonary arterial hypertension (PAH) is a serious disease of the arteries connecting the lungs to the heart (the pulmonary arteries).

Contact

Global Medical Information
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
CH-4123 Allschwil
Switzerland
Contact
Phone: +41 61 565 65 65
Fax: +41 61 565 65 00
Contact us onlineHow to get to us

CLINICAL TRIALS

Image for CLINICAL TRIALS

Actelion is committed to inform the medical community and the public about its clinical trials by making them publicly available on the Actelion clinical study register and other public databases.

Image for CLINICAL TRIALS

Actelion is committed to inform the medical community and the public about its clinical trials by making them publicly available on the Actelion clinical study register and other public databases.